Rocío
Aller De La Fuente
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (5)
2024
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068
-
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia
2022
-
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective
Seminars in Liver Disease, Vol. 42, Núm. 4, pp. 434-445
-
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
Scientific Reports, Vol. 12, Núm. 1
2020
-
Dietary Approach to NAFLD
Non-Alcoholic Fatty Liver Disease: A 360-degree Overview (Springer International Publishing), pp. 271-287